Skin diseases greatly vary in symptoms and severity depending upon the cause of the infection, and can be temporary or permanent, painful or painless, and in some cases the skin diseases may be genetic or situational. There are many different types of skin diseases, which in some cases may be minor, or in rare conditions can be life threatening. Many skin diseases are often limited to affecting the skin itself, but in some cases, they might affect the internal organs of the human body as well.
Some common skin diseases include acne, moles, rashes, psoriasis, rosacea, chicken pox, etc. Temporary skin diseases include diseases such as contact dermatitis, Keratosis pilaris, etc. while permanent skin diseases include conditions such as vitiligo, psoriasis, rosacea, etc. Skin conditions have a wide range of symptoms, of which skin irregularities are the most prominent symptoms of the skin diseases, which include, peeling skin, a rash, which might be painful or itchy, dry, cracked skin, open sores or lesions, a loss of skin pigment etc.
Skin disease treatment market is segmented on the basis of types of skin diseases, by products, by end users, and by regions. Based on types, skin diseases treatment market can be further segmented into, Infectious skin diseases (bacterial, Fungal, Viral), genetic skin diseases, allergic skin diseases, autoimmune skin diseases, cancers and others. Based on products type, skin diseases treatment market can be further segmented into, antihistamines, medicated creams and ointments, laser therapy, antibiotics, antifungals, vitamins and steroids, and other targeted prescription medications. End users include, Hospitals, Dermatology Clinics, Aesthetic centers, skin care clinics, and others. The rising number of skin diseases is attributed to various factors such as increasing incidences of infections like bacterial, and fungal skin infections, allergic skin reactions and skin cancers.
Rising incidences of skin diseases, emergence of new and advanced methods of skin treatment such as minimally invasive techniques like aesthetic services, laser treatment, and other methods, increasing awareness of skin diseases and their effects, growing medical tourism, and rising disposable incomes across the world, are some major factors driving the skin disease treatment market. Based on geography, the skin disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and The Middle East and Africa. North America accounted for the largest share of the skin diseases treatment market, owing to number of factors such as technological advancements in the field of skin care management, high disposable incomes, rising incidences of allergic skin reactions and skin cancers, followed by Europe. However, Asia Pacific region is expected to register a strong growth during the forecast period of 2016-2024, owing to factors such as large population base, increasing awareness of skin disorders and their effects, and emergence of new and advanced technologies and treatment methods.
Some of the major players in the skin diseases treatment market include, Allergen, Plc., AbbVie, Inc., Celgene Corporation, Eli Lilly and Company, Galderma, GlaxoSmithKline plc., Incyte Corporation, Almirall S.A., Pfizer, Inc., and Valeant Pharmaceuticals International, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.